Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants.

Suvimol Niyomnaitham,Anan Jongkaewwattana,Atibordee Meesing,Nawamin Pinpathomrat,Sira Nanthapisal,Nattiya Hirankarn,Sarawut Siwamogsatham,Suppachok Kirdlarp,Romanee Chaiwarith,Saranath Lawpoolsri,Supranee Phanthanawiboon,Arunee Thitithanyanont,Pokrath Hansasuta, Sansanee Chaiyaroj,Punnee Pitisuttithum

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases（2023）

引用 4|浏览17

暂无评分

摘要

Immune responses after day 28 when boosting at longer intervals after the two-dose CoronaVac was optimal. Half doses met the noninferiority criteria compared with the full dose by all the immune assays assessed.

查看译文

关键词

Booster strategy,COVID-19,Immune response,Vaccine

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要